原发性乳腺癌的预后指数
A prognostic index in primary breast cancer.
作者信息
Haybittle J L, Blamey R W, Elston C W, Johnson J, Doyle P J, Campbell F C, Nicholson R I, Griffiths K
出版信息
Br J Cancer. 1982 Mar;45(3):361-6. doi: 10.1038/bjc.1982.62.
Abstract
From a multiple-regression analysis of prognostic factors and survival in a series of 387 patients with primary breast cancer, a prognostic index has been constructed, based on lymph-node stage, tumour size and pathological grade. This index is more discriminating than lymph-node stage alone, and enables a larger group of patients to be identified with a very poor prognosis.
摘要
通过对387例原发性乳腺癌患者的预后因素和生存情况进行多元回归分析，构建了一个基于淋巴结分期、肿瘤大小和病理分级的预后指数。该指数比单纯的淋巴结分期更具区分性，能够识别出更多预后极差的患者群体。
相似文献
1
A prognostic index in primary breast cancer.原发性乳腺癌的预后指数
Br J Cancer. 1982 Mar;45(3):361-6. doi: 10.1038/bjc.1982.62.
2
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.cT1-2 和 cN0 期乳腺癌患者前哨淋巴结转移的预后意义最小。
World J Surg Oncol. 2019 Feb 23;17(1):41. doi: 10.1186/s12957-019-1585-9.
3
Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.保乳手术联合放疗治疗早期乳腺癌的治疗结果及预后因素
Jpn J Clin Oncol. 2005 Mar;35(3):126-33. doi: 10.1093/jjco/hyi039.
4
[Lobular invasive breast cancer prognostic factors: About 940 patients].小叶浸润性乳腺癌的预后因素：约940例患者
Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16.
5
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].[早期浸润性乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗。OTOASOR试验的早期结果]
Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765.
6
Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.在原发性乳腺癌患者中，进行了 10 年随访，检测了原发肿瘤、同期淋巴结转移和异时性复发中生物标志物的表达和圣加仑分子亚型分类。
Breast Cancer Res Treat. 2013 Jul;140(1):93-104. doi: 10.1007/s10549-013-2617-8. Epub 2013 Jun 27.
7
[Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].[小乳腺癌伴多发腋窝淋巴结转移的临床特征及预后因素]
Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):615-8.
8
Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.Raf/MEK/ERK信号通路与腋窝淋巴结转移乳腺癌患者临床病理特征及预后的相关性
Technol Cancer Res Treat. 2018 Jan 1;17:1533034617754024. doi: 10.1177/1533034617754024.
9
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者：长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
10
[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].腹股沟淋巴结转移乳腺癌患者的临床病理特征及预后因素：附17例报告
Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010.
引用本文的文献
1
Data-Driven Sustainable Campaigns to Decipher Invasive Breast Cancer Features.数据驱动的可持续运动以解读浸润性乳腺癌特征。
ACS Biomater Sci Eng. 2025 Aug 11;11(8):5107-5121. doi: 10.1021/acsbiomaterials.5c00731. Epub 2025 Jul 25.
2
Modification of the nuclear pleomorphism score in the Modified Bloom-Richardson grading for invasive breast cancer.浸润性乳腺癌改良 Bloom-Richardson 分级中核多形性评分的修改
PLoS One. 2025 Jul 18;20(7):e0327860. doi: 10.1371/journal.pone.0327860. eCollection 2025.
3
Prediction of the 70-gene signature (MammaPrint) high versus low risk by nomograms among axillary lymph node positive (LN+) and negative (LN-) Chinese breast cancer patients, a retrospective study.通过列线图预测中国腋窝淋巴结阳性（LN+）和阴性（LN-）乳腺癌患者中70基因特征（MammaPrint）的高风险与低风险：一项回顾性研究
BMC Cancer. 2025 Jul 1;25(1):1128. doi: 10.1186/s12885-025-14507-z.
4
Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study.使用机器学习模型优化复发风险/Prosigna检测指南：一项瑞典多中心研究
Breast. 2025 May 7;82:104489. doi: 10.1016/j.breast.2025.104489.
5
Quantifying the Influence of Psychosocial Characteristics, Supportive Care Needs and Quality of Life on Breast Cancer Survival.量化心理社会特征、支持性护理需求和生活质量对乳腺癌生存的影响。
Psychooncology. 2025 Apr;34(4):e70146. doi: 10.1002/pon.70146.
6
Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All.探索辅助性CDK4/6抑制剂在激素受体阳性早期乳腺癌中的潜力：适用于所有人的一致方法。
Cancers (Basel). 2025 Feb 7;17(4):561. doi: 10.3390/cancers17040561.
7
The functional TNF-αG > a single-nucleotide polymorphism (rs1800629): association with the predictive indices of breast cancer carcinogenesis.功能性肿瘤坏死因子-α基因G > A单核苷酸多态性（rs1800629）：与乳腺癌发生的预测指标的关联
Breast Cancer Res Treat. 2025 Feb;210(1):57-70. doi: 10.1007/s10549-024-07536-y. Epub 2024 Nov 21.
8
An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction.一种用于乳腺癌预后和免疫治疗反应性预测的衰老相关长链非编码RNA特征的建立
Pharmgenomics Pers Med. 2024 May 23;17:251-270. doi: 10.2147/PGPM.S450960. eCollection 2024.
9
Canine Mammary Tumors as a Potential Model for Human Breast Cancer in Comparative Oncology.犬乳腺肿瘤作为比较肿瘤学中人类乳腺癌的潜在模型。
Vet Med Int. 2024 May 10;2024:9319651. doi: 10.1155/2024/9319651. eCollection 2024.
10
Nanocage-incorporated engineered destabilized 3'UTR ARE of ERBB2 inhibits tumor growth and liver and lung metastasis in EGFR T790M osimertinib- and trastuzumab-resistant and ERBB2-expressing NSCLC via the reduction of ERBB2.纳米笼包裹的工程化不稳定3'UTR ERBB2的ARE通过降低ERBB2抑制EGFR T790M奥希替尼和曲妥珠单抗耐药且ERBB2表达的非小细胞肺癌的肿瘤生长以及肝和肺转移。
Front Oncol. 2024 Apr 18;14:1344852. doi: 10.3389/fonc.2024.1344852. eCollection 2024.
本文引用的文献
1
Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes.乳腺癌病例的生存情况与原发肿瘤及区域淋巴结结构的关系。
Surg Gynecol Obstet. 1955 May;100(5):543-51.
2
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后；对1409例病例的研究，其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
3
Relationship between primary breast tumor receptor status and patient survival.原发性乳腺肿瘤受体状态与患者生存率之间的关系。
Cancer. 1980 Dec 15;46(12 Suppl):2765-9. doi: 10.1002/1097-0142(19801215)46:12+<2765::aid-cncr2820461404>3.0.co;2-c.
4
A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia.用于预测儿童急性淋巴细胞白血病缓解期时长的诊断评分
Br J Cancer. 1980 Dec;42(6):841-9. doi: 10.1038/bjc.1980.331.
5
The use of prognostic factors in predicting survival for breast cancer patients.预后因素在预测乳腺癌患者生存率中的应用。
J Chronic Dis. 1966 Aug;19(8):923-33. doi: 10.1016/0021-9681(66)90008-7.
6
The relative significance of prognostic factors in breast carcinoma.乳腺癌预后因素的相对重要性。
Br J Cancer. 1971 Dec;25(4):646-56. doi: 10.1038/bjc.1971.80.
7
Prognostic factors in mammary carcinoma.
Acta Radiol Ther Phys Biol. 1976 Feb;15(1):1-16. doi: 10.3109/02841867609132703.
8
Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria.无法手术的肺癌患者的生存情况：基于简单临床标准的预后变量整合
Cancer. 1977 Jan;39(1):303-13. doi: 10.1002/1097-0142(197701)39:1<303::aid-cncr2820390147>3.0.co;2-u.
9
Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.人类原发性乳腺肿瘤中雌激素受体含量与组织学分级之间的关系。
Br J Cancer. 1978 Dec;38(6):745-8. doi: 10.1038/bjc.1978.282.
10
Prognostic factors in breast cancer -- the formation of a prognostic index.乳腺癌的预后因素——预后指数的形成
Clin Oncol. 1979 Sep;5(3):227-36.
Zotero 插件